A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine

PURPOSE: This study evaluated the re-challenge of S-1 or cisplatin in combination with docetaxel in metastatic gastric cancer (MGC) that had progressed on a cisplatin plus either S-1 or capecitabine regimen. MATERIALS AND METHODS: Patients with progressive disease after first-line cisplatin plus S-1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Res Treat
Hlavní autoři: Lee, Keun-Wook, Kim, Bum Jun, Kim, Mi-Jung, Han, Hye Sook, Kim, Jin Won, Park, Young Iee, Park, Sook Ryun
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Cancer Association 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512362/
https://ncbi.nlm.nih.gov/pubmed/27764906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.216
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky